Nestlé Health Science is celebrating five years of innovation at its global research and development hub in Bridgewater. Co-located at the company’s U.S. headquarters on Route 202, the Nestlé Product ...

As weight-loss medications become more popular, Nestlé Health Science wants to ensure that consumers who are taking the drugs have access to comprehensive nutritional support. The global leader in ...

BRIDGEWATER, N.J., June 6, 2024 /PRNewswire/ -- Seres Therapeutics, Inc. (MCRB), announced today that it has agreed to a non-binding memorandum of understanding with Nestlé Health Science in which ...

ZURICH (Reuters) -Nestle intends to keep its Health Science unit, Chairman Paul Bulcke said in a newspaper interview published on Sunday, after the food giant announced it was replacing its CEO Mark ...

REDWOOD CITY, Calif., Dec. 27, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it has entered into a purchase agreement with Nestlé Health ...

Codexis, Inc. (NASDAQ:CDXS) entered a purchase deal with Nestlé S.A.(OTC:NSRGY) Nestlé Health Science for CDX-7108, a potential treatment for exocrine pancreatic insufficiency (EPI). Under the terms ...

Nestlé plans to retain its Health Science unit, chairman Paul Bulcke has said in an interview discussing the change in CEO at the world’s largest food group. In the wake of last week’s announcement ...

BRIDGEWATER, N.J., March 31, 2026 /PRNewswire/ -- Nestlé Health Science, a global leader in nutritional health and wellness, and the Gerald J. and Dorothy R. Friedman School of Nutrition Science and ...

BRIDGEWATER, NJ. — Keto Kind and Superfrau have been selected as winners for the Nestle Health Science Innovate Forward: The Longevity Challenge. The challenge is a joint initiative between Nestle ...

BOSTON--(BUSINESS WIRE)--Amwell ® (NYSE: AMWL), a leader in hybrid health care enablement, today announced a collaboration with Nestlé Health Science, a global leader in the science of nutrition, to ...

Upon closing, Seres to receive $175M cash infusion, including an upfront payment, prepayment of a future commercial milestone payment, and an equity investment in Seres common stock, less ...

Seres Therapeutics, Inc. announced the receipt of a $50 million installment payment from Nestlé Health Science related to the sale of its VOWST business, contributing to the company's financial ...